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Several independent studies and meta-analyses aimed at identifying genomic regions linked to bipolar disorder (BP)
have failed to ﬁnd clear and consistent evidence of linkage regions. Our hypothesis is that combining the original
genotype data provides beneﬁts of increased power and control over sources of heterogeneity that outweigh the
difﬁculty and potential pitfalls of the implementation. We conducted a combined analysis using the original genotype
data from 11 BP genomewide linkage scans comprising 5,179 individuals from 1,067 families. Heterogeneity among
studies was minimized in our analyses by using uniform methods of analysis and a common, standardized marker
map and was assessed using novel methods developed for meta-analysis of genome scans. To date, this collaboration
is the largest and most comprehensive analysis of linkage samples involving a psychiatric disorder. We demonstrate
that combining original genome-scan data is a powerful approach for the elucidation of linkage regions underlying
complex disease. Our results establish genomewide signiﬁcant linkage to BP on chromosomes 6q and 8q, which
provides solid information to guide future gene-ﬁnding efforts that rely on ﬁne-mapping and association approaches.
Introduction
Bipolar disorder (BP) is a common and often disabling
mood disorder, from which individuals suffer from epi-
sodes of mania and depression. The symptoms of mania
include an expansive, elevated, or irritable mood; in-
ﬂated self-esteem; grandiosity; decreased need for sleep;
increased talkativeness; racing thoughts; distractibility;
increased goal-directed activity; and excessive involve-
ment in pleasurable activities with a high potential for
painful consequences (National Institute of Mental
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Health [NIMH] Genetics Workgroup 1999). The symp-
toms of depression include depressed mood, diminished
interest or pleasure in activities, change in sleeping pat-
terns, psychomotor agitation or retardation, fatigue or
loss of energy, feelings of worthlessness or excessive
guilt, inability to concentrate or act decisively, and re-
current thoughts of death or suicide (NIMH Genetics
Workgroup 1999). Bipolar disorder I (BPI) is deﬁned by
the occurrence of one or more manic or mixed (manic/
depressive) episodes and is often accompanied by at least
one major depressive episode (American Psychiatric As-
sociation [APA] 1994). Bipolar disorder II (BPII) is char-
acterized by milder manic episodes (hypomania) and re-
current major depressive episodes (APA 1994).
It is estimated that BPI has a lifetime prevalence of
∼0.5%–1.5%, whereas BPII has a lifetime prevalence
of ∼0.5% (Kessler et al. 1994; Weissman et al. 1996).
The burden of illness for BP is considerable. It is esti-
mated that completed suicide occurs in 10%–15% of
individuals who received a diagnosis of BP (APA 1994),
as well as a higher rate of unemployment and marital
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dysfunction and an increased use of health services
(Weissman et al. 1991). Further, treatment of BP is not
curative and is not completely effective in mitigating
symptoms. Extensive research efforts have been directed
at uncovering the etiology of BP, with the hope that
more-effective treatment and prevention strategies can
be developed.
The importance of genetic factors in BP has been
repeatedly conﬁrmed using family, twin, and adoption
studies. The recurrence risk ratio is ∼7 for ﬁrst-degree
relatives and as high as 60 for MZ twins (NIMH Ge-
netics Workgroup 1999). Twin studies have suggested
heritability estimates of ∼80%, providing evidence that
genes contribute strongly to the familial aggregation of
BP (Tsuang and Faraone 2000; Smoller and Finn 2003).
The mode of inheritance for BP is complex and likely
involves multiple genes. The speciﬁc number of suscep-
tibility loci, the recurrence risk ratio attributable to each
locus, and the degree of the interaction between loci are
unknown. Nevertheless, it is clear that a single major
locus does not explain any substantial proportion of the
familial aggregation of BP (NIMH Genetics Workgroup
1999).
Genetic complexity underlying BP provides at least one
plausible explanation for the many insigniﬁcant and/or
inconsistent ﬁndings among gene-mapping efforts over
the past 15 years. There have been numerous genome-
wide scans of BP, and linkage signals from individual
studies have been reported throughout the genome, in-
cluding chromosomes 1, 4, 6, 10, 12, 13, 18, 21, 22, and
X (reviewed by Baron [2002]). Consistent with other
disorders of complex etiology, independent replication
of linkage signals for BP has not been convincing.
The lack of reproducibility of linkage ﬁndings among
different studies may reﬂect a variety of study-speciﬁc
issues. For example, different studies have variable power
to detect linkage, depending on the sample size and the
number of affected individuals who meet ascertainment
criteria for the study. There are often differences in the
diagnosis and ascertainment of affected individuals, dif-
ferences in the phenotypic model chosen for analysis
(i.e., inclusion of recurrent unipolar depression [RUD]),
or differences in the modeling parameters (i.e., pene-
trance, disease-allele frequency, etc.) speciﬁed for para-
metric linkage analysis. The genetic markers, marker
densities, and the genetic maps used for each study can
also vary considerably. Finally, in addition to false-posi-
tive results, there may be a considerable amount of ge-
netic heterogeneity of BP among the populations studied.
Meta-analysis is one strategy that offers a systematic
and quantitative approach to summarizing evidence from
multiple genome scans. Two relevant meta-analyses of
BP linkage studies have been published recently. Badner
and Gershon (2002) developed the multiple scan prob-
ability (MSP) method to conduct a meta-analysis of re-
ported P values in published linkage-analysis studies.
Chromosomal regions that had a P value !.01 from 11
independently published BP linkage studieswere included
in their meta-analysis. The meta-analysis provided evi-
dence of two susceptibility loci residing on chromosomes
13q and 22q. In a similar effort, Segurado et al. (2003)
conducted a meta-analysis that included up to 18 inde-
pendent linkage studies that used the genome scanmeta-
analysis (GSMA) method (Wise et al. 1999). In contrast
to the meta-analysis by Badner and Gershon (2002),
Segurado et al. (2003) reported no signiﬁcant chromo-
somal regions linked to BP across the genome.
An advantage of the MSP and GSMA approaches is
that they require only linkage statistics and/or P values
from each study. However, many of the study-speciﬁc
issues discussed above are also likely to affect thesemeta-
analyses. One method to circumvent many of the issues
encountered with the meta-analysis of linkage studies is
through the use of the original genotype data rather than
summary statistics (Levinson et al. 2003). Here, we ex-
plore whether combining the original genotype data pro-
vides beneﬁts of increased power and control over sources
of heterogeneity that outweigh the difﬁculty andpotential
pitfalls of the implementation. We report that, in this
case, combining the original genotype data was clearly
worth the effort, since we were able to demonstrate sig-
niﬁcant linkage to loci on chromosomes 6q and 8q while
controlling for potential sources of heterogeneity.
Material and Methods
Source and Structure of the Original Data Sets
Our analysis included original genotype data from 11
independent linkage studies. Studies excluded from the
present meta-analysis include genome scans that had (1)
a unique population origin (i.e., founder populations) or
(2) a unique ascertainment scheme (i.e., lithium-depen-
dent BP); (3) studies containing largely multiplex com-
plex pedigrees (these tended to be smaller studies with
!20 pedigrees); or (4) no original data available. Table
1 summarizes the populations represented, as well as the
numbers of families and individuals per data set. In sum,
the 11 data sets include 1,067 families of 5,179 indi-
viduals from North America, Italy, Germany, Portugal,
the United Kingdom, Ireland, and Israel. In addition,
table 1 provides the number of markers that were geno-
typed from each study, as well as the number of markers
that were used for the analysis (see the “Genotyping,
Genetic Markers, andMap” section). Collection of blood
and family history information for each study was done
with informed consent and approval of the respective
institutional review boards (or equivalent). We used raw
genotype data that corresponded to the initial genome-
wide scans from each data set (avoiding ﬁne-mapping
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Table 1
Overview of Data Sets
DATA SET REFERENCE POPULATION RACE
NO. OF
PEDIGREES
NO. OF
GENOTYPED
INDIVIDUALS
NO. OF GENETIC
MARKERSa
Genotyped Mapped
Bonn Cichon et al. 2001 Germany, Israel, Italy White 75 387 389 386
Columbia Liu et al. 2003 Israel, U.S. White 40 358 334 333
Johns Hopkins 1 McInnis et al. 2003b U.S. Mixed 63 562 823 802
Johns Hopkins 2 Fallin et al. 2004 U.S. White 40 175 381 380
NIMH Wave 1 NIMH Genetics Initiative Bipolar Group 1997 U.S. Mixed 95 525 357 351
NIMH Wave 2 Dick et al. 2002; McInnis et al. 2003a;
Willour et al. 2003; Zandi et al. 2003
U.S. Mixed 55 348 465 458
NIMH Wave 3 Dick et al. 2003; NIMH Human Genetics
Initiative Web Site
U.S. Mixed 220 982 372 372
NIMH Wave 4 NIMH Human Genetics Initiative Web Site U.S. Mixed 274 1,053 384 384
Portuguese Pato et al. 2004 Portugal White 16 102 346 342
UCSD Kelsoe et al. 2001 Canada, U.S. White 20 163 331 324
Wellcome Trust Bennett et al. 2002 Great Britain, Ireland White 151 509 380 378
Total 1,067 5,179 4,562 4,510
a Genotypedpnumber of markers genotyped (autosomal only). Mappedpnumber of markers mapped to the common marker map (autosomal only).
b ARPpall possible ARPs; FSpall possible full-sibling pairs ; IFpfamilies informative for nonparametric allele-sharing linkage analysis.
c Ascertainment scheme: 1SBpat least one affected sibling; 1FDpat least one affected ﬁrst-degree relative; 1FDpat least one affected ﬁrst- or greater-degree
relative; 2FDpat least two affected ﬁrst- or greater-degree relatives.
d Diagnosis of the relative(s) of proband (satisfying ascertainment scheme). BPNOSpbipolar disorder–not otherwise speciﬁed.
data, etc.), with the exception of the NIMH Wave 3, in
which case we used the data available via the Web re-
pository (NIMH Human Genetics Initiative Web Site).
Family Ascertainment and Assessment
Detailed descriptions of family ascertainment, clinical
assessment, and diagnostic criteria are available in the
respective primary references for each data set (table 1).
With the exception of the Columbia and University of
California at San Diego (UCSD) data sets, all studies in-
cluded a proband with a Diagnostic and StatisticalMan-
ual of Mental Disorders, 3rd edition (DSM-IIIR), Re-
search Diagnostic Criteria (RDC), or DSM-IV diagnosis
of BPI but differed with respect to the number, type of
relationship, and diagnosis of additional familymembers
used for ascertainment conditions. A brief overview of
pertinent information is provided in table 1.
Genotyping, Genetic Markers, and Map
Detailed information about specimen collection,DNA
extraction, and genotyping methods for each data set
can be found in the primary references for each data set
(table 1). In all 11 data sets, variable-repeat microsatel-
lite genetic markers were genotyped for family members
with available DNA for each of the 22 autosomes. Geno-
types from the X chromosome were not available from
all data sets; therefore, they were excluded from the an-
alysis. The number of markers genotyped for each data
set was relatively consistent (∼350–400), with the noted
exception of the Johns Hopkins 1 data set ( ).np 823
A unique feature available to meta-analyses of linkage
studies that use original genotype data is the ability to
construct a standardized genetic map. We mapped re-
spective markers from each data set to one common sex-
averaged map, using the Rutgers Combined Linkage–
Physical Map of the Human Genome (Kong et al. 2004;
Rutgers Combined Linkage–PhysicalMap of theHuman
Genome Web Site) as the backbone. If the genetic loca-
tion (in cM) of a particular marker was found on the
Rutgers map, then that location was used. Otherwise, if
the genetic location from the Rutgers map was not avail-
able for a particular marker, we ﬁrst determined the physi-
cal location (in bp) of that marker, using the National
Center for Biotechnology Information (NCBI) Build 35.1
(University of California–Santa Cruz [UCSC] Genome
Bioinformatics). We then identiﬁed the physical loca-
tions of two ﬂanking markers that were found on the
Rutgers map. The resultant genetic location of the un-
known marker location was interpolated under the as-
sumption that the ratio of the distances betweenmarkers
on the physical map was the same as the ratio of the
distances on the genetic map. If we could not identify a
marker either on the Rutgers map or via the NCBI, that
marker was discarded. We were able to map the vast
majority of markers from each data set to the standard-
ized, common map (table 1).
Pooling Procedure
We combined the raw genotype data from the 11 stud-
ies into one large pooled data set. To accommodate the
variation in allele coding across different studies, we cre-
ated unique marker names for each data set, such that
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NO. OF SUBJECTS WITH BPb
DIAGNOSTIC AND ASCERTAINMENT CRITERIA Narrow Broad
Diagnostic
Criterion(a)
Diagnosis
of Proband Schemec
Diagnosis of
Affected Relatived Total ARP FS IF Total ARP FS IF
DSM-IIIR BPI 1SB BPI, SAB, BPNOS, RUD 103 62 45 27 124 98 69 36
RDC BPI, SAB 2FD BPI, SAB 115 97 38 31 200 309 92 35
RDC BPI 2FD BPI, BPII, SAB, RUD 125 73 65 32 216 243 169 55
DSM-IV BPI 1FD BPI, BPII 73 33 19 22 95 53 38 40
DSM-IIIR, RDC BPI 1FD BPI, SAB 226 164 94 64 298 294 164 81
DSM-IIIR, RDC BPI 1FD BPI, SAB 135 85 54 39 174 170 110 46
DSM-IV BPI 1SB BPI, SAB 489 310 254 189 534 370 288 193
DSM-IV BPI 1SB BPI, SAB 620 416 338 234 665 482 380 243
DSM-IV BPI 1FD BPI, BPII, SAB 43 35 27 15 44 37 27 15
DSM-IIIR BPI, BPII 2FD BPI, BPII, SAB, RUD 27 11 7 7 41 21 15 12
DSM-IV BPI 1SB BPI, BPII, BPNOS, RUD 288 159 150 109 313 195 186 122
2,251 1,445 1,091 769 2,423 2,272 1,538 878
no two data sets shared an identical marker name (even
if the same marker had been genotyped across more than
one study). We then pooled the raw genotypes from each
data set, generating missing genotypes for each occur-
rence of a marker from one of the other data sets. Pool-
ing linkage samples in this way enabled us to estimate
allele frequencies within study, which minimized any bias
introduced through estimation of allele frequencies across
the entire, potentially heterogeneous, pooled sample.
Error Detection
We used a variety of programs to check forMendelian
errors, including family-based association test (FBAT)
(Laird et al. 2000) and PEDSTATS (Abecasis et al. 2002).
Any incompatible genotypes were set to “unknown” for
the entire family for that locus. In addition, we used the
software package MERLIN (Abecasis et al. 2002) for
its error-detection feature to identify unlikely genotypes
( from the r-statistic). Any unlikely genotypes de-P ! .05
tected by MERLIN were set to “unknown.” Relationship
errors were assessed using graphical relationship repre-
sentation (Abecasis et al. 2001). Individuals with geno-
type data inconsistent with their pedigree relationships,
including MZ twins, were excluded from the analysis.
Finally, individuals with no genotype or phenotype in-
formation who were not needed to deﬁne relationships
between other individuals in a pedigree were removed
using MERLIN’s trim option.
Affection-Status Models
Two hierarchical deﬁnitions for BP affection statuswere
used: (1) a narrow model that included individuals who
received a diagnosis of BPI only and (2) a broad model
that included individuals who received a diagnosis of
either BPI or BPII. Relatives who received a diagnosis
of disorders other than BPI or BPII were coded as “un-
known.” The use of multiple affection models is com-
mon practice in linkage analysis of BP, primarily because
diagnostic boundaries are ill deﬁned and the underlying
genetic model for BP is unknown. Table 1 provides an
overview of the diagnostic criteria used for each data
set, as well as the number of affected relative pairs
(ARPs) that have complete phenotype and genotype in-
formation for both the narrow and broad BP deﬁnitions;
we have the original genotype data for 1,445 ARPs for
the narrow phenotype deﬁnition and 2,272 ARPs for the
broad phenotype deﬁnition. Note that families ascer-
tained through non-BPI–affected probands but that met
criteria for the BP broad phenotype model were included
in the analysis (i.e., BPII-affected probands fromUCSD).
ARP LOD-Score Methods
The analytic objective of the project was to conduct
nonparametric multipoint linkage analysis with use of
the pooled sample for each of the two phenotype deﬁ-
nitions. Marker-allele frequencies were estimated within
study by use of founder genotypes. If there were no avail-
able founder genotypes for a particular family, a random
family member with genotype informationwas used. Use
of the default allele frequency calculation in MERLIN
(all genotyped individuals) did not alter the results (data
not shown). We used MERLIN’s implementation of the
Whittemore and Halpern (1994) algorithm to test for
allele sharing among all affected individuals, and we gen-
erated the nonparametric LOD score via the Kong and
Cox (1997) linear model. We also estimated the linkage
information at each analysis position, using MERLIN’s
measure of entropy. At 1-cM intervals, across all 22 au-
tosomal chromosomes, we analyzed each of the 11 data
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sets individually, as well as the pooled data set compris-
ing the 11 data sets combined.
Genomewide Signiﬁcance Thresholds
We followed the guidelines of Lander and Kruglyak
(1995) for genomewide signiﬁcant and suggestive link-
age thresholds. We estimated critical values for the LOD
score from the pooled analysis, using the method de-
scribed by Bacanu (2005); to compute genomewide sig-
niﬁcant and suggestive critical values, this method esti-
mates the correlation between Gaussian statistics at ad-
jacent map points. The threshold for genomewide sig-
niﬁcance was established at a LOD score of 3.03. Ge-
nomewide suggestive thresholds were established at a
LOD score of 1.75. The thresholds were Bonferroni ad-
justed to account for the fact that two phenotypes were
analyzed. In our study, the correlation between narrow
and broad BP linkage statistics was 0.85. Our simula-
tions (data not shown) suggest that, for this magnitude
of correlation, Bonferroni-adjusted thresholds are very
close to their empirical counterparts. Consequently, for
the present analysis, we report only the Bonferroni ad-
justment for multiple testing. For comparison, we also
calculated simulated thresholds (1,000 genomewide rep-
licates) and conﬁrmed that these were similar to the criti-
cal values obtained by the Bacanu (2005) method.
Assessment of Heterogeneity
The identical-by-descent (IBD) sharing probabilities
of each affected sibling pair (ASP) generated inMERLIN
was used to calculate the maximum-likelihood estimates
of sharing 0, 1, and 2 alleles IBD via the expectation-
maximization algorithm. All possible ASPs for each fami-
ly were used and weighted equally. The bootstrap vari-
ance estimation procedure (described below) automati-
cally adjusts for correlation between sib pairs among
families. Using a custom-written program, we estimated
the IBD proportions (treating each sibling pair as in-
dependent) fromMERLIN’s IBD output by allowing the
maximum-likelihood IBD estimates to convergewithout
triangle constraints (Holmans 1993). We chose to use
the unconstrained estimates, since imposing the triangle
constraints in the presence of heterogeneity may be less
powerful (Dizier et al. 2000). In addition, combination
of estimates over studies is more meaningful with the
unconstrained estimates. Note that our estimation pro-
cedure is identical to that of GENEHUNTER (Kruglyak
et al. 1996), with the exception of the triangle-constraint
restriction. Following a more traditional meta-analytic
approach, we used estimates of mean IBD (IBDm) sharing
and its variance to quantify heterogeneity among the 11
data sets at selected regions along the genome. Using
the unconstrained estimates of sharing 0, 1, or 2 alleles
IBD (ibd0, ibd1, ibd2) for ASPs, we calculated the IBDm
( ) separately for each study. Note that0.5# ibd  ibd1 2
use of the unconstrained probabilities allows the esti-
mated IBDm for a study to be !0.5, whereas use of the
constraints forces IBDm to be at least 0.5. To derive the
variance of the IBDm, we used a bootstrap procedure
developed for estimating the variance of IBDm sharing
among ASPs in linkage analysis samples (M.B.M. and
N.M.L., unpublished data). The Q-statistic was utilized
to provide a formal test of heterogeneity (Laird andMos-
teller 1990). Then, continuing along the traditional meta-
analytic path, we pooled the study-speciﬁc estimates of
IBDm, using a random-effects model (Laird and Mos-
teller 1990) that allows for the incorporation of be-
tween-study heterogeneity and therefore a more realistic
summary measure of IBDm, as well as more accurate CIs.
Gu et al. (1998) provide a detailed description of this
general approach in the context of ASP linkage samples.
Results
LOD-Score Results
Overall, the average information content across all
chromosomes of the pooled analysis was ∼0.58 (range
0.49–0.63), which is consistent with genomewide scans
that used ∼10-cM marker density. Only one individual
genome scan yielded a LOD score 13; eight other LOD
scores 12 were found in individual scans. Some of these
will be discussed later, in the context of the pooled re-
sults; additional results are available on request. The
number of families informative for narrow and broad
BP per data set is listed in table 1.
Table 2 displays the results for the pooled analysis.
The largest Kong and Cox (1997) LOD score observed
was with use of the narrow phenotype, which achieved
genomewide signiﬁcance ( ) on chromosomeLOD 1 3.03
6, at 115 cM (LOD 4.19). With the use of this same
phenotype deﬁnition, no other chromosome achieved
genomewide signiﬁcance, although we observed ge-
nomewide suggestive linkage ( ) signals onLOD 1 1.75
chromosomes 9 (LOD 2.04), 8 (LOD 1.99), and 20
(LOD 1.91). Table 2 also shows the corresponding re-
sults from analysis of the broad phenotype. The LOD
score found on chromosome 8 at 151 cM (LOD 3.40)
obtained using this phenotype deﬁnition exceeds the
genomewide signiﬁcance threshold. Chromosome 9 re-
vealed genomewide suggestive thresholds (LOD 2.04) in
the location identical or near to that found with the
narrow BP phenotype analysis. Note that the LOD score
for chromosome 6 (LOD 1.74) was substantially lower
for broad BP compared with narrow BP. In summary, two
regions on chromosomes 6 (narrow BP) and 8 (broad BP)
achieved genomewide signiﬁcance. These two regions
were selected for more-detailed analysis and presentation.
Figures 1A and 1B display the LOD scores from chro-
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Table 2
Results from the Pooled Analysis
CHROMOSOME
Narrow BP Broad BP
Genetic
Locationa
(cM)
Physical
Locationb
(Mb) LOD
Genetic
Locationa
(cM)
Physical
Locationb
(Mb) LOD
1 200 185.0 .41 79 44.9 .59
2 92 68.0 .97 92 68.0 1.10
3 1 .6 .19 69 44.5 .14
4 152 154.0 .39 154 154.5 .56
5 79 67.0 .31 78 66.0 .11
6 115 108.5 4.19c 115 108.5 1.74
7 187 157.1 .57 187 157.1 .70
8 152 135.4 1.99d 151 134.5 3.40c
9 46 24.5 2.04d 48 25.6 2.06d
10 85 70.2 .07 50 25.8 .20
11 72 60.0 .54 72 60.0 .57
12 155 126.5 .40 155 126.5 .13
13 44 42.4 .62 50 46.4 .46
14 79 86.5 .54 79 86.5 .19
15 21 29.4 .95 25 31.2 .73
16 30 12.1 .18 35 13.4 .85
17 98 64.3 1.36 98 64.3 .91
18 70 44.9 1.47 87 58.5 1.05
19 73 51.5 .33 37 14.6 .13
20 12 4.2 1.91d 12 4.2 1.71
21 60 43.0 .06 48 39.2 .03
22 2 15.0 .12 9 16.0 .03
a Genetic location from the uniﬁed marker map.
b Physical location (approximate) from theRutgersCombinedLinkage-PhysicalMap.
c Genomewide signiﬁcant ( ).LOD 1 3.03
d Genomewide suggestive ( ).LOD 1 1.75
mosomes 6 (narrow BP) and 8 (broad BP), respectively.
In particular, we plotted the LOD score from the pooled
data set superimposed on the plot of the LOD scores
from each of the 11 component data sets (ﬁgs. 1A and
1B). For chromosome 6, the NIMH Wave 3 data set is
the only data set that achieves a LOD score of 12.0,
despite the fact that the pooled signal surpassed a LOD
score of 4.0 (ﬁg. 1A). There were three signals in this
region that appear to achieve the highest LOD scores
under the pooled signal (NIMH Wave 3, Portuguese, and
Columbia). For chromosome 8, we found that no indi-
vidual data set reached a LOD score of 2.0, despite the
fact that the pooled signal exceeded 3.0 (ﬁg. 1B). There
were also clear overlapping signals from component data
sets (e.g., Johns Hopkins 1 and NIMHWave 3). Removal
of the nonwhite families (and re-estimation of allele fre-
quencies) from the NIMH samples ( ) did not im-np 38
pact the pooled linkage signal for either chromosome 6
or 8.
Assessment of Heterogeneity Results
In the region that encompasses the signiﬁcant linkage
signals on chromosome 6 and 8, there was no evidence
of heterogeneity among data sets as tested via the Q-
statistic ( ; results not shown). Using the locationP 1 .10
from each chromosome that reveals the peak LOD score,
we provide a forest plot of the IBDm and 95% CIs for
each of the component data sets, as well as the summary
IBDm estimate and 95%CI (ﬁgs. 2A and 2B).We selected
the 115-cM position for chromosome 6 (ﬁg. 2A). Here,
we see that only two data sets (NIMH Wave 3 and Por-
tuguese) display signiﬁcant excess allele sharing, whereas
all others have 95% CIs that include 0.50. As seen in
ﬁgure 2A, the combined estimate of IBDm, which is the
random-effects summary estimate that uses each com-
ponent data set’s IBDm estimate and variance, suggests
an excess in allele sharing at the position for the studies
combined ( ; 95% CI 0.51–0.59). Figure 2BIBD p 0.55m
displays chromosome 8 at the 151-cM position. Here,
two data sets display signiﬁcant excess sharing (NIMH
Wave 3 and Johns Hopkins 1) and another (Columbia)
displays borderline excess sharing. The summary estimate
of IBDm also demonstrates excess sharing at this posi-
tion, despite nine of the component data sets’ 95% CIs
including 0.50 ( ; 95% CI 0.52–0.56). NoteIBD p 0.54m
that the summary IBDm CIs are not adjusted for genome-
wide comparison.
Although global tests for heterogeneity are often un-
Figure 1 Relative contribution of component data sets to the pooled linkage signals. The LOD scores from the pooled analysis (solid
black line) are overlaid with the LOD scores from the data set–speciﬁc analysis (the horizontal dotted line indicates the genomewide signiﬁcance
threshold). A, Narrow BP phenotype, chromosome 6. B, Broad BP phenotype, chromosome 8. BONNpBonn; COLUpColumbia; JHU1pJohns
Hopkins 1; JHU2pJohns Hopkins 2; NIW1pNIMH Wave 1; NIW2pNIMH Wave 2; NIW3pNIMH Wave 3; NIW4pNIMH Wave 4;
PORTpPortuguese; UCSDpUCSD; WELLpWellcome Trust; POOLppooled sample.
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Figure 2 IBDm and 95% CIs for the component data sets,
as well as the random-effects summary point estimate. A, Narrow BP
phenotype, chromosome 6 at 115 cM. B, Broad BP phenotype, chro-
mosome 8 at 151 cM. BONNpBonn; COLUpColumbia; JHU1p
Johns Hopkins 1; JHU2pJohns Hopkins 2; NIW1pNIMH Wave 1;
NIW2pNIMH Wave 2; NIW3pNIMH Wave 3; NIW4pNIMH
Wave 4; PORTpPortuguese; UCSDpUCSD; WELLpWellcome Trust;
SUMMprandom-effects summary IBDm.
derpowered, the IBDm procedure was able to detect sta-
tistically signiﬁcant among-study heterogeneity at re-
gions throughout the genome, including regions outside
the linkage signals on chromosomes 6 and 8. In particu-
lar, the 6pter region and the 35–45-cM region on chro-
mosome 6 have substantial heterogeneity (Q-statistic
) as does the 40–50-cM region of chromosomeP ! .001
8 (Q-statistic ).P ! .001
There is mounting evidence that unselected sibling pairs
tend to share more than half of their alleles IBD (Elston
et al. 2005). To provide reassurance that the observed
allele sharing among ASPs in the present study is attrib-
utable to affection status, we evaluated discordant sib-
ling pairs as well. Estimation of IBDm in unaffected sib-
lings (excluding all psychiatric diagnoses, if available)
paired with affected siblings resulted in either null shar-
ing or slightly less than null sharing (not signiﬁcant) at
the locations of the reported linkage signals for each of
the data sets that provided adequate diagnostic informa-
tion (data not shown).
Discussion
To our knowledge, this is the largest and most compre-
hensive collaboration involving the original genotype data
for BP linkage analysis. We identiﬁed loci on chromo-
somes 6q and 8q as meeting genomewide signiﬁcance
and loci on 9p and 20p as meeting suggestive linkage.
Our results show that the extra expense and effort re-
quired to obtain original genotype data from genome
scans has substantial beneﬁts. Our observations from
pooling data for the present analysis are consistent with
an increase in power, since linkage signals from the
pooled sample were generally higher than the linkage
signal from any one component data set. Utilizing the
more traditional meta-analytic approach, we constructed
a summary measure of IBDm to assess the among-study
heterogeneity.
Heterogeneity
In general, replication of linkage signals from complex
diseases such as BP is likely to be complicated by known
sources of heterogeneity among linkage studies. In par-
ticular, sources of heterogeneity include different popula-
tions under investigation, varied number of affected in-
dividuals (with varying diagnoses) per family, varied fami-
ly size, different ascertainment criteria, varied instruments
of assessment and diagnostic criteria, different sets of
marker genotypes and corresponding marker maps, as
well as dissimilar analytic methods. We restricted our
analyses to uniform disease classiﬁcations and the use
of common methods, including a standardized common
marker map. Both within- and between-study hetero-
geneity likely remains, since subjects were ascertained,
were assessed, and received a diagnosis with consider-
able variation. The presence of genetic heterogeneity
may also limit the utility of pooling original data geared
toward the identiﬁcation of candidate loci. Despite these
issues, the regions of signiﬁcant or suggestive linkage
lacked evidence of substantial heterogeneity. However,
tests of heterogeneity are often underpowered, and ac-
ceptance does not preclude heterogeneity in these re-
gions. On the other hand, substantial heterogeneitywould
likely limit the extent to which signals could be detected;
such regions may be worthy of further study.
Phenotype Deﬁnition
Our results provide some support for the view that
genetic inﬂuences on BPI and BPII may be distinguish-
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able. Our most signiﬁcant result was seen for narrow
BP (BPI-only phenotype) on chromosome 6q. When the
analysis was expanded to include BPII, the linkage signal
on chromosome 6q was attenuated, despite the increase
in the number of ARPs. In contrast, removal of the in-
dividuals with BPII from the analysis reduced the evi-
dence of linkage on chromosome 8q. It has been argued
that the diagnostic reliability of BPII may be less robust
than that of BPI, although this may not be true when
careful diagnostic procedures are applied (Simpson et al.
2002). Genetic epidemiologic data suggest that BPII is
probably a genetically heterogeneous entity inwhich some
cases are genetically distinct from BPI, whereas others
are part of a spectrum that includes BPI and/or unipolar
depression (Smoller and Finn 2003).
It could be argued from our results that a locus on
chromosome 6q is linked speciﬁcally to BPI, so that the
addition of subjects with BPII resulted in “phenotypic
noise,” effectively pulling the estimates of allele sharing
toward the null. On the other hand, inclusion of subjects
with BPII enhanced the linkage signal on chromosome
8q, suggesting that a locus in this region may inﬂuence a
broader bipolar spectrum phenotype. It should be noted
that, because we did not analyze a BPII-only phenotype,
we cannot address the question of whether the 8q locus
or loci elsewhere in the genome have more-speciﬁc ef-
fects on BPII itself.
Prior Meta-Analyses in Context
Table 3 provides an overview of the variations of dif-
ferent data sets included in each of the two prior meta-
analyses as well as the present combined analysis. Over-
all, the MSP meta-analysis included 8 data sets (Badner
and Gershon 2002), the GSMA (Segurado et al. 2003)
included 18 data sets, and the present combined analysis
included 11 data sets (table 3). Only four data sets (Bonn,
NIMH Wave 1, UCSD, and Wellcome Trust) were com-
mon across all three meta-analyses. There were addi-
tional data sets that were common to one or more analy-
ses; however, different variations of the data were often
included. For example, the Johns Hopkins 1 data set was
included in all three analyses; however, only the GSMA
and the present combined analysis used the full sample
(65 pedigrees). Much of the variability in the data sets—
as well as data-set versions used for eachmeta-analysis—
is largely explained through what was available at the
time of each of the meta-analyses. The Johns Hopkins
2; NIMH Waves 2, 3, and 4; and Portuguese data sets
became available after the MSP and GSMA analyses.
Therefore, as is true in any meta-analysis context, up-
dating analyses to include new information as it becomes
available is essential to the conﬁrmation and identiﬁca-
tion of genomic regions that may harbor disease-suscep-
tibility loci.
Chromosomes 6 and 8
The strongest support derived from this analysis under
the narrow BP phenotype deﬁnition is for chromosome
6q and under the broad BP phenotype deﬁnition, chro-
mosome 8q. Because of practical considerations, an ex-
haustive review of the BP linkage analysis literature will
not be the focus of this discussion (for more detailed
review, see Baron [2002]). Rather, a brief discussion of
each region follows.
Linkage signals of varying degrees on chromosome 6
have been reported from data sets used in the present
analysis as well as other data sets not included here.
Figure 1A provides a graphical representation of the rela-
tive contribution from each of the component data sets
to the signal on 6q. The NIMH Wave 3, Portuguese,
and Columbia data sets appear to be themost inﬂuential.
From the estimated IBDm, all studies in this analysis—
with the exception of Bonn, Johns Hopkins 1, andNIMH
Wave 2—showed excess allele sharing in ASPs at the
pooled linkage peak (ﬁg. 2A). The NIMH Human Ge-
netics Initiative also noted linkage at this region (at or
near marker D6S1021) through a linkage analysis in-
corporating an interaction effect with 6p (Schulze et al.
2004). The study of the Portuguese sample reported a
linkage signal to chromosome 6q22 in a follow-upmarker
scan with use of high-density genotyping (Middleton et
al. 2004). In addition, theWellcome Trust study reported
a signal on 6q through a follow-up analysis that included
larger sample size and additional marker genotypes (Lam-
bert et al. 2005). Further, in a Danish study that was
not a part of the present meta-analysis, Ewald et al.
(2002) reported a maximum LOD score of 3.8 for the
marker (D6S1021) closest to the maximum LOD score
in our pooled sample analysis. Another study that used
families from northern Sweden also reported a signal
from parametric linkage analysis of chromosome 6q;
however, that signal appears nearer to the smaller pooled
linkage signal observed in the present meta-analysis (Ven-
ken et al. 2005). Moreover, although not statistically
signiﬁcant, Segurado et al. (2003) reported bin 6.4 as
meeting a PAveRnk of !.10 for their model 1 (BPI or schizo-
affective disorder-bipolar type [SAB]). Badner and Ger-
shon (2002) did not report linkage to BP on 6q.
The pooled signal from chromosome 8 appears to be
driven by the Bonn, Johns Hopkins 1, and NIMH Wave
3 data (ﬁg. 1B). All studies in our analysis, aside from
NIMHWaves 2 and 4, show excess allele sharing among
ASPs at the linkage peak (ﬁg. 2B). In addition, a genome-
wide scan of psychosis in the Columbia data set provided
evidence of linkage to 8q24 (Park et al. 2004). Aside
from previous reports from data sets included in this
collaboration, we are unaware of any linkage signals that
have been reported for 8q from studies outside the col-
laboration. Segurado et al. (2003) reported that bin 8.6
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failed to reach genomewide signiﬁcance; however, they
report that 8q might contain a locus that is “weakly
linked” to BP (PAveRnk !.05) for their model 2 (BPI, BPII,
and SAB). Badner and Gershon (2002) did not report
linkage to BP on 8q.
Conclusions
The present analysis is the ﬁrst comprehensive collabora-
tion of BP linkage studies to use original genotype data
that is aimed at identifying potential candidate regions
for future investigation. Using the pooled data, we dem-
onstrated genomewide signiﬁcant linkage to chromo-
somes 6q and 8q and genomewide suggestive linkage to
chromosomes 9p and 20p. The ﬁnding on chromosome
6q, which is based on the BPI phenotype, is supported
by some of the individual studies analyzed herein, as
well as by other studies that we could not include in our
analysis. When subjects with BPII are included in the
analysis, the results for chromosome 6q are diminished,
and a locus on 8q becomes signiﬁcant. Evidence for the
8q locus appears limited to studies included in this an-
alysis. Effect size estimates from the ASP analysis suggest
relative risks (ls) of 1.34 and 1.26 attributable to loci
on chromosomes 6q and 8q, respectively. Thus, the ma-
jority of the genetic constituents underlying BP remain
unidentiﬁed, which suggests that their discovery may re-
quire more-elaborate and -focused investigations of bi-
polar-spectrum phenotypes, as well as more-reﬁnedmeth-
ods for gene mapping.
We have demonstrated that combining data from dis-
parate genome scans provides an effective mechanism
for summarizing quantitative information and that lack
of consistent ﬁndings in individual scans does not pre-
clude ﬁnding a signiﬁcant region in the combined data.
There are particular strengths for use of the original
data, in that it allows control of many potential sources
of variability in the original studies. Fortunately, origi-
nal genome-scan data are becoming increasingly avail-
able, such as those from the NIMH Human Genetics
Initiative, and our results suggest these efforts should be
supported. Our approach offers a powerful methodol-
ogy for the identiﬁcation of linkage regions underlying
complex diseases, such as BP, for which there are likely
multiple disease-susceptibility loci.
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